Cyclogyl

You should not receive this medicine if you have angle-closure glaucoma.

You should not receive this medicine if you have ever had a severe allergic reaction to cyclopentolate ophthalmic, or if you have angle-closure glaucoma.

To make sure cyclopentolate ophthalmic is safe for you, tell your doctor if you have glaucoma.

FDA pregnancy category C. It is not known whether cyclopentolate ophthalmic will harm an unborn baby. Tell your doctor if you are pregnant.

It is not known whether cyclopentolate ophthalmic passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Ocular: Increased intraocular pressure, burning, photophobia, blurred vision, irritation, hyperemia, conjunctivitis, blepharoconjunctivitis, punctate keratitis, synechiae have been reported.

Non-ocular: Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration. These disturbances include ataxia, incoherent speech, restlessness, hallucinations, hyperactivity, seizures, disorientation as to time and place, and failure to recognize people. This drug produces reactions similar to those of other anticholinergic drugs, but the central nervous system manifestations as noted above are more common. Other toxic manifestations of anticholinergic drugs are skin rash, abdominal distention in infants, unusual drowsiness, tachycardia, hyperpyrexia, vasodilation, urinary retention, diminished gastrointestinal motility and decreased secretion in salivary and sweat glands, pharynx, bronchi and nasal passages. Severe manifestations of toxicity include coma, medullary paralysis and death.